Bayforest Capital »

Nektar Therapeutics shares owned by Bayforest Capital

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Bayforest Capital from 13F filings

Historical chart of Bayforest Capital investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Bayforest Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Bayforest Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $96k 1.7k 56.90

More positions owned by Bayforest Capital

Solaredge Technologies (SEDG)
Peloton Interactive Cl A Com (PTON)
Crown Castle Intl (CCI)
Mercury Computer Systems (MRCY)
Cirrus Logic (CRUS)
Dollar Tree (DLTR)
Humana (HUM)
Trinet (TNET)
InterDigital (IDCC)
CVR Energy (CVI)
Celsius Hldgs Com New (CELH)
Frontdoor (FTDR)
Irhythm Technologies (IRTC)
Jack Henry & Associates (JKHY)
Kilroy Realty Corporation (KRC)

View all positions for Bayforest Capital

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics